Follow
Peter Fridy
Peter Fridy
Verified email at rockefeller.edu
Title
Cited by
Cited by
Year
A robust pipeline for rapid production of versatile nanobody repertoires
PC Fridy, Y Li, S Keegan, MK Thompson, I Nudelman, JF Scheid, ...
Nature methods 11 (12), 1253-1260, 2014
3902014
A conserved family of enzymes that phosphorylate inositol hexakisphosphate
S Mulugu, W Bai, PC Fridy, RJ Bastidas, JC Otto, DE Dollins, TA Haystead, ...
Science 316 (5821), 106-109, 2007
2662007
A strategy for dissecting the architectures of native macromolecular assemblies
Y Shi, R Pellarin, PC Fridy, J Fernandez-Martinez, MK Thompson, Y Li, ...
Nature methods 12 (12), 1135-1138, 2015
1312015
Structural analysis and detection of biological inositol pyrophosphates reveal that the family of VIP/diphosphoinositol pentakisphosphate kinases are 1/3-kinases
H Lin, PC Fridy, AA Ribeiro, JH Choi, DK Barma, G Vogel, JR Falck, ...
Journal of Biological Chemistry 284 (3), 1863-1872, 2009
1312009
Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinases
PC Fridy, JC Otto, DE Dollins, JD York
Journal of Biological Chemistry 282 (42), 30754-30762, 2007
1212007
Characterization of a selective inhibitor of inositol hexakisphosphate kinases
U Padmanabhan, DE Dollins, PC Fridy, JD York, CP Downes
Journal of Biological Chemistry 284 (16), 10571-10582, 2009
1032009
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
FD Mast, PC Fridy, NE Ketaren, J Wang, EY Jacobs, JP Olivier, T Sanyal, ...
Elife 10, e73027, 2021
352021
Supervillin binding to myosin II and synergism with anillin are required for cytokinesis
TC Smith, PC Fridy, Y Li, S Basil, S Arjun, RM Friesen, J Leszyk, BT Chait, ...
Molecular Biology of the Cell 24 (23), 3603-3619, 2013
352013
Vip1 is a kinase and pyrophosphatase switch that regulates inositol diphosphate signaling
DE Dollins, W Bai, PC Fridy, JC Otto, JL Neubauer, SG Gattis, KPM Mehta, ...
Proceedings of the National Academy of Sciences 117 (17), 9356-9364, 2020
332020
Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexes
PC Fridy, MK Thompson, NE Ketaren, MP Rout
Analytical biochemistry 477, 92-94, 2015
192015
Optimizing selection of large animals for antibody production by screening immune response to standard vaccines
MK Thompson, PC Fridy, S Keegan, BT Chait, D Fenyö, MP Rout
Journal of immunological methods 430, 56-60, 2016
172016
Biochemical analysis of inositol phosphate kinases
JC Otto, S Mulugu, PC Fridy, ST Chiou, BN Armbruster, AA Ribeiro, ...
Methods in enzymology 434, 171-185, 2007
132007
Nanobody repertoires for exposing vulnerabilities of SARS-CoV-2
FD Mast, PC Fridy, NE Ketaren, J Wang, EY Jacobs, JP Olivier, T Sanyal, ...
BioRxiv, 2021
102021
Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker
MS Taylor, C Wu, PC Fridy, SJ Zhang, Y Senussi, JC Wolters, WC Cheng, ...
bioRxiv, 2023.01. 25.525462, 2023
22023
Proteomic elucidation of the targets and primary functions of the picornavirus 2A protease
AA Serganov, Y Udi, ME Stein, V Patel, PC Fridy, CM Rice, M Saeed, ...
Journal of Biological Chemistry 298 (6), 2022
22022
Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2
FR Cross, PC Fridy, NE Ketaren, FD Mast, S Li, JP Olivier, K Pecani, ...
Journal of Biological Chemistry 299 (3), 2023
12023
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2 (preprint)
PC Fridy, NE Ketaren, J Wang, EY Jacobs, T Sanyal, KR Molloy, ...
2021
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2 (preprint)
FD Mast, PC Fridy, NE Ketaren, J Wang, EY Jacobs, JP Olivier, T Sanyal, ...
2021
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2
PC Fridy, NE Ketaren, J Wang, EY Jacobs, T Sanyal, KR Molloy, ...
2021
Nanobody-Based Interactomic Studies of Single Transcripts During mRNA Maturation
PC Fridy
2016
The system can't perform the operation now. Try again later.
Articles 1–20